SITEMAP
ARMY.MIL
AKO
SEARCH
About USAMRIID
Scientific Publications
Medical Library
Business Opportunities
Employment
Education & Training
Biosafety
Reference Materials
Related Links
Newsroom/Media
Contact Us
Search
>> Home >> Scientific Publications >> 2001
2012 • 2011 • 2010 • 2009 • 2008 • 2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001• 2000
— 2001 —
Ahmed SA, MP Byrne, M Jensen, HB Hines, E Brueggeman, LA Smith. 2001. Enzymatic autocatalysis of botulinum A neurotoxin. J Prot Chem 20:221-231.
Blow JA, MJ Turell, AL Silverman, ED Walker. 2001. Stercorarial shedding and transtadial transmission of hepatitis B virus by common bed bugs (Hemiptera: Cimicidae). J MeD Entomol 38:694-700.
Bray M. 2001. The role of type 1 interferon response in the resistance of mice to filovirus infection. J Gen Virol 82:1365-1373.
Bray M, S Hatfill, L Hensley, JW Huggins. 2001. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J Comp Pathol 125:243-253.
Cieslak TJ. 2001. Medical consequences of biological warfare: The ten commandments of management. Mil Med 166:11-12.
Coffman JD, J Zhu, JM Roach, S Bavari, RG Ulrich, SL Giardina. 2001. Production and purification of a recombinant staphylococcal enterotoxin B vaccine candidate expressed in Escherichia coli. Prot Expr Purif 24:302-312.
Culpepper RC, WD Pratt. 2001. Advances in medical biological defense technology. Clin Lab Med 21:679-689.
DeShazer D, DM Waag, DL Fritz, DE Woods. 2001. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence factor. Microb Pathogen 30:253-269.
Dohm DJ, MJ Turell. 2001. Effect of incubation at overwintering temperatures on the replication of West Nile virus in New York Culex pipiens (Diptera:Culicidae). J Med Entomol 38:462-464.
Erwin JL, LM DaSilva, S Bavari, SF Little, AM Friedlander, TC Chanh. 2001. Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect Immun 69:1172-1177.
Fellows PF, MK Linscott, BE Ivins, MLM Pitt, CA Rossi, PH Gibbs, AM Friedlander. 2001. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 19:3241-3247.
Gibb
TR, DA Norwood, N Woolen, EA Henchal. 2001. Development and evaluation of a fluorogenic 5'-nuclease assay to detect and differentiate between Ebola Zaire and Ebola Sudan. J Clin Microbiol 39:4125-4130.
Gibb TR, M Bray, TW Geisbert, KE Steele, WM Kell, KJ Davis, NK Jaax. 2001. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. J Comp Pathol 125:233-242.
Hale ML. 2001. Microtiter-based assay for evaluating the biological activity of ribosome-inactivating proteins. Pharmacol Toxicol 88:255-260.
Hale ML, TA Campbell, YG Campbell, SE Fong, BG Stiles. 2001. Development of a time-resolved immunofluorometric assay for quantitation of mucosal and systemic antibody responses. J Immunol Meth 257:83-92.
Hart MK, C Lind, R Bakken, M Robertson, R Tammariello, GV Ludwig. 2001. Onset and duration of protective immunity to IA/B and IE strains of Venezuelan equine encephalitis virus in vaccinated mice. Vaccine 20:616-622.
Hawley RJ, PR Pittman, JA Nerges. 2001. Maximum containment for researchers exposed to biosafety level 4 agents, pp 35-53. In JY Richmond (ed), Anthology of Biosafety: II, Publication committee of the American Biological Safety Association, Mundalein, IL.
Hawley RJ, EM Eitzen Jr. 2001. Protection against biological warfare agents, pp 1161-1167. In SS Block (ed), Disinfection, Sterilization, and Preservation, Lippincott Williams & Wilkins, Philadelphia PA.
Hawley RJ. 2001. Biosafety training - a practical, realistic, and reasonable approach. The Loop, newsletter of the National Registry of Microbiologists. 27:2-3.
Hawley RJ, EM Eitzen Jr. 2001. Biological weapons - a primer for microbiologists. Ann Rev Microbiol 55:235-253.
Henchal EA, JD Teska, GV Ludwig, DR Shoemaker, JW Ezzell. 2001. Current laboratory methods for biological threat agent identification. Clin Lab Med 21:661-678.
Hevey M, D Negley, L VanderZanden, RF Tammariello, J Geisbert, C Schmaljohn, JF Smith, PB Jahrling, AL Schmaljohn. 2001. Marburg virus vaccines: Comparing classical and new approaches. 20:586-593.
Hooper JW, D Li. 2001. Vaccines against hantaviruses, pp 171-191. In CS Schmaljohn, ST Nichol (ed), Current Topics in Microbiology and Immunology, Vol 256, Springer-Verlag, Berlin.
Hooper JW, DM Custer, E Thompson, CS Schmaljohn. 2001. DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in rhesus monkeys. J Virol 75:8469-8477.
Hooper JW, T Larsen, DM Custer, CS Schmaljohn. 2001. A lethal disease model for hantavirus pulmonary syndrome. Virology 289:6-14.
Kortepeter MG, MR Krauss. 2001. Tuberculosis infection after humanitarian assistance, Guantanamo Bay, 1995. Mil Med 166:116-120.
Kortepeter MG, TJ Cieslak, EM Eitzen Jr. 2001. Bioterrorism. J Environ Hlth 63:21-24.
Krakauer T. 2001. Suppression of endotoxin- and staphylococcal exotoxin-induced cytokines and chemokines by a phospholipase C inhibitor in human peripheral blood mononuclear cells. Clin Diag Lab Immunol 8:449-453.
Krakauer T, C Russo. 2001. Serum cytokine levels and antibody response to influenza vaccine in the elderly. Immunopharmacol Immunotoxicol 1:35-41.
Krakauer T, BQ Li, HA Young. 2001. The flavonoid baicalin inhibits staphylococcal superantigen-induced inflammatory cytokines and chemokines. FEBS Lett 500:52-55.
LeClaire RD, S Bavari. 2001. Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality. Antimicrob Agents Chemother 45:460-463.
Lee JS, P Pushko, MD Parker, MT Dertzbaugh, LA Smith, JF Smith. 2001. Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system. Infect Immun 69:5709-5715.
Ludwig GV, MJ Turell, P Vogel, JP Kondig, W Kell, JF Smith, WD Pratt. 2001. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice. Am J Trop Med Hyg 64:49-55.
Marty AM, RM Conran, MG Kortepeter. 2001. Recent challenges in infectious diseases. Biological pathogens as weapons and emerging endemic threats. Clin Lab Med 21:411-420.
Marvaud J-C, T Smith, ML Hale, MR Popoff, LA Smith, BG Stiles. 2001. Clostridium perfringens iota-toxin: Mapping of receptor binding and LA docking domains on LB. Infect Immun 69:2435-2441.
O’Quinn AL, EM Wiegand, JA Jeddeloh. 2001. Burkholderia pseudomallei kills the nematode Caenorhabditis elegans using an endotoxin-mediated paralysis. Cell Microbiol 3:381-393.
Olson MA. 2001. Electrostatic effects on the free-energy balance in folding a ribosome-inactivating protein. Biophys Chem 91:219-229.
Olson MA. 2001. Calculations of free-energy contributions to protein-RNA complex stabilization. Biophys J 81:1841-1853.
Pastel RH. 2001. Collective behaviors: Mass panic and outbreaks of multiple unexplained symptoms. Mil Med 166:44-46.
Pastel RH, J Mulvaney. 2001. Fear of radiation in U.S. military medical personnel. Mil Med 166:80-82.
Pitt MLM, SF Little, BE Ivins, P Fellows, J Barth, JF Hewetson, P Gibbs, M Dertzbaugh, AM Friedlander. 2001. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine 19:4768-4773.
Pittman PR, JA Mangiafico, CA Rossi, TL Cannon, PH Gibbs, GW Parker, AM Friedlander. 2001. Anthrax vaccine: Increasing intervals between the first two doses enhances antibody response in humans. Vaccine 19:213-216.
Pless DD, ER Torres, EK Reinke, S Bavari. 2001. High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A. Infect Immun 69:570-574.
Poli MA, FJ Lebeda. 2001. An overview of clostridial toxins, pp 293-304. In EJ Massaro (ed), Handbook of Neurotoxicology, Humana Press Inc, Totowa, NJ.
Pushko P, J Geisbert, M Parker, P Jahrling, J Smith. 2001. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J Virol 75:11677-11685.
Pushko P, M Bray, GV Ludwig, D Parker, A Schmaljohn, A Sanchez, PB Jahrling, JF Smith. 2001. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 19:142-153.
Sardelis MR, MJ Turell. 2001. Ochlerotatus j. japonicus in Frederick County, Maryland: Discovery, distribution, and vector competence for West Nile virus. J Am Mosq Control Asso 17:137-141.
Sardelis MR, MJ Turell, DJ Dohm, ML O’Guinn. 2001. Vector competence of selected North American Culex and Coquillettidia mosquitoes for West Nile virus. Emerg Infect Dis 7:1018-1022.
Schmidt JJ, RG Stafford, CB Millard. 2001. High throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D, and F. Anal Biochem 296:130-137.
Smee DF, M Bray, JW Huggins. 2001. Intracellular phosphorylation of carbocyclic 3-deazaadenosine, an anti-Ebola virus agent. Antivir Chem Chemother 12:251-258.
Smith DR, CA Rossi, TM Kijek, EA Henchal, GV Ludwig. 2001. Comparison of dissociation-enhanced lanthanide fluorescent immunoassays to enzyme-linked immunosorbent assays for detection of staphylococcal enterotoxin B, Yersinia pestis-specific F1 antigen, and Venezuelan equine encephalitis virus. Clin Diag Lab Immunol 8:1070-1075.
Srinivasan A, CN Kraus, D DeShazer, PM Becker, JD Dick, L Spacek, JG Bartlett, WR Byrne, DL Thomas. 2001. Glanders in a military research microbiologist. N Eng J Med 345:256-258.
Steele KE, K Stabler, L VanderZanden. 2001. Cutaneous DNA vaccination against Ebola virus by particle bombardment: Histopathology and alteration of CD3-positive dendritic epidermal cells. Vet Pathol 38:203-215.
Steele K, B Crise, A Kuehne, W Kell. 2001. Ebola virus glycoprotein demonstrates differential cellular localization in infected cell types of nonhuman primates and guinea pigs. Arch Pathol Lab Med 125:625-630.
Stiles BG, AR Garza, RG Ulrich, JW Boles. 2001. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model. Infect Immun 69:2031-2036.
Turell MJ, ML O’Guinn, DJ Dohm, JW Jones. 2001. Vector competence of North American mosquitoes (Diptera:Culicidae) for West Nile virus. J Med Entomol 38:130-134.
Turell MJ, MR Sardelis, DJ Dohm, ML O’Guinn. 2001. Potential North American vectors of West Nile virus. Ann NY Acad Sci 951:317-324.
Welkos SL, SF Little, A Friedlander, D Fritz, P Fellows. 2001. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147:1677-1685.
Wilson JA, MK Hart. 2001. Protection from Ebola virus mediated by cytotoxic T-lymphocytes specific for the viral nucleoprotein. J Virol 75:2660-2664.
Wilson JA, M Bray, R Bakken, MK Hart. 2001. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins. Virology 286:384-390.
Wilson JA, CM Bosio, MK Hart. 2001. Ebola virus: The search for vaccines and treatments. Cell Mol Life Sci 58:1826-1841.
Zaucha GM, PB Jahrling, TM Geisbert, JR Swearengen, L Hensley. 2001. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab Invest 81:1581-1600
2012 • 2011 • 2010 • 2009 • 2008 • 2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001• 2000